Growth Hormone Secretion and Sensitivity in Men with Idiopathic Osteoporosis
β Scribed by P. Gillberg, A.G. Johansson, W.F. Blum, T. Groth, S. Ljunghall
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 316 KB
- Volume
- 68
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We studied the growth hormone (GH) response to GH-releasing hormone (GHRH) and the thyroid-stimulating hormone (TSH) response to thyrotropin-releasing hormone (TRH) in four groups of patients with dementia and examined whether GH and TSH secretion is altered in patients with Alzheimer's disease. The
## Abstract Male idiopathic osteoporosis (MIO) is a metabolic bone disease that is characterized by low bone mass, microstructural alterations, and increased fracture risk in otherwise healthy men. Although the detailed pathophysiology of MIO has yet to be clarified, evidence increasingly suggests
Changes in brain peptides and neurotransmitters are thought to elicit alterations of growth hormone (GH) secretion in dementia. Baseline GH levels and hormone responses to GH-releasing hormone (GHRH)-administered alone or after pyridostigmine pretreatment-were evaluated in 17 patients, aged 52-83, w